Ani Pharmaceuticals Inc. (anip 2.25 09/01/29)
13F holders, Q3 2025 (September 30)3holders
$2.56avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Ani Pharmaceuticals Inc. (anip 2.25 09/01/29) in their 13F filings. The largest holders were Absolute Investment Advisers, LLC ($16.1M), Boussard & Gavaudan Investment Management LLP ($14.1M) and Bank of New York Mellon Corp ($984K).
- Company
- Ani Pharmaceuticals Inc. (anip 2.25 09/01/29)
- CUSIP
- 00182CAC7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $31.2M |
| Exits | 0 | $0 |
Ownership 3 holders
| Absolute Investment Advisers, LLC | 2.02% | New | 11,473,000 | $16.1M |
| Boussard & Gavaudan Investment Management LLP | 3.09% | New | 10,000 | $14.1M |
| Bank of New York Mellon Corp | 0.00% | New | 700,000 | $984K |
"% of holder's portfolio" is ANI PHARMACEUTICALS INC (ANIP 2.25 09/01/29)'s weight in each manager's 13F, not the share of Ani Pharmaceuticals Inc. (anip 2.25 09/01/29) the manager owns.